Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Sunrun Inc (RUN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs Sunrun Inc — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.99 (market cap $1.74B), while Sunrun Inc trades at $7.64 (market cap $1.83B). The key difference: Nuvation Bio Inc. Class A Common Stock and Sunrun Inc are close in size by market cap, and Nuvation Bio Inc. Class A Common Stock is trading nearer its 52-week high, Sunrun Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 1 Days and Sunrun Inc for 16 Days on average.
| NUVB | RUN | |
|---|---|---|
Market Cap | $1.74B | $1.83B |
Volume | 9,289,619 | 8,672,852 |
Sector | Health | Energy |
52-Week High | $9.54 | $21.41 |
52-Week Low | $3.41 | $7.59 |
Typical Hold Time | 1 Days | 16 Days |
Enterprise Value | $1.33B | $16.35B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Sunrun (RUN) trades at $7.55, down 0.79% recently, with technical indicators showing bearish momentum despite strong analyst support. The company demonstrates solid profitability with 35.29% gross margins and has beaten earnings expectations for three consecutive quarters. Recent partnerships with Tesla and Voltus highlight strategic positioning in distributed energy, though negative operating cash flow and high debt levels present challenges.
The stock appears fundamentally undervalued with a P/E of 5.16 and P/S of 0.59, while analyst consensus targets $16.33 representing 116% upside potential. However, persistent negative cash flows, high interest expenses, and solar industry headwinds from borrowing costs create significant execution risks that could limit near-term performance despite the attractive valuation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About Sunrun Inc
Sunrun Inc. is one of the largest residential solar, battery storage, and energy services companies in the United States. The company provides solar panel installations, battery backup systems, and energy management solutions to homeowners. Sunrun primarily uses a solar-as-a-service model, offering customers solar leases and power purchase agreements (PPAs), which allow homeowners to adopt solar energy with little to no upfront cost. The company's mission is to create a planet run by the sun.
Read more on RUN →
